Numerical scoring for the BILAG-2004 index.

Numerical scoring for the BILAG-2004 index.
复制标题

DOI:
10.1093/rheumatology/keq026
复制
发表时间:
2010-09
期刊:
Rheumatology (Oxford, England)
影响因子:
--
通讯作者:
Gordon C
Gordon C
中科院分区:
其他
文献类型:
--
作者:
Yee CS;Cresswell L;Farewell V;Rahman A;Teh LS;Griffiths B;Bruce IN;Ahmad Y;Prabu A;Akil M;McHugh N;D'Cruz D;Khamashta MA;Isenberg DA;Gordon C

文献摘要

参考文献

被引文献

相似文献

Objective.为BILAG-2004指数制定一个附加数值评分方案。方法. SLE患者被招募到这个多中心的横断面研究。在每次评估时,收集疾病活动和治疗的数据。使用逻辑回归模型,通过9个系统中的BILAG-2004指数评分,作为活动性疾病的指标,增加治疗。由于两者均表示不活动,因此将D和E的评分设定为0,并用作拟合模型中的基线。该模型用于确定A-C级的数值。比较了不同的评分方案。结果共有来自369名SLE患者的1510项评估。建议用于经典BILAG指数的编码方案(A = 12,B = 5,C = 1,D/E = 0和A = 9,B = 3,C = 1,D/E = 0)不能很好地拟合数据。根据分析结果并与经典BILAG指数的数值编码方案一致,推荐了一种编码方案(A = 12,B = 8,C = 1,D/E = 0)。结论基于BILAG-2004指数治疗决策的合理附加数值评分方案为A = 12、B = 8、C = 1、D = 0和E = 0。
Objective. To develop an additive numerical scoring scheme for the BILAG-2004 index. Methods. SLE patients were recruited into this multi-centre cross-sectional study. At every assessment, data were collected on disease activity and therapy. Logistic regression was used to model an increase in therapy, as an indicator of active disease, by the BILAG-2004 index score in the nine systems. As both indicate inactivity, scores of D and E were set to 0 and used as the baseline in the fitted model. The models were used to determine the numerical values for Grades A–C. Different scoring schemes were compared. Results. There were 1510 assessments from 369 SLE patients. The coding schemes suggested for the Classic BILAG index (A = 12, B = 5, C = 1, D/E = 0 and A = 9, B = 3, C = 1, D/E = 0) did not fit the data well. A coding scheme (A = 12, B = 8, C = 1 and D/E = 0) was recommended, based on analysis results and consistency with the numerical coding scheme of the Classic BILAG index. Conclusion. A reasonable additive numerical scoring scheme based on treatment decision for the BILAG-2004 index is A = 12, B = 8, C = 1, D = 0 and E = 0.
DOI: 10.1093/rheumatology/kep183
发表时间: 2009-12
期刊: Rheumatology (Oxford, England)
影响因子: --
作者:
Cresswell L;Yee CS;Farewell V;Rahman A;Teh LS;Griffiths B;Bruce IN;Ahmad Y;Prabu A;Akil M;McHugh N;Toescu V;D'Cruz D;Khamashta MA;Maddison P;Isenberg DA;Gordon C
通讯作者: Gordon C
DOI: 10.1093/rheumatology/keh624
发表时间: 2005-07-01
期刊: RHEUMATOLOGY
影响因子: 5.5
作者:
Isenberg, DA;Rahman, A;Gordon, C
通讯作者: Gordon, C
DOI: 10.1002/art.23130
发表时间: 2007-12-01
影响因子: --
作者:
Yee, Chee-Seng;Farewell, Vernon;Gordon, Caroline
通讯作者: Gordon, Caroline
DOI: 10.1002/art.22162
发表时间: 2006-10-01
影响因子: --
作者:
Yee, Chee-Seng;Farewell, Vernon;Gordon, Caroline
通讯作者: Gordon, Caroline
DOI: 10.1093/rheumatology/kep064
发表时间: 2009-06
期刊: Rheumatology (Oxford, England)
影响因子: --
作者:
Yee CS;Farewell V;Isenberg DA;Griffiths B;Teh LS;Bruce IN;Ahmad Y;Rahman A;Prabu A;Akil M;McHugh N;Edwards C;D'Cruz D;Khamashta MA;Maddison P;Gordon C
通讯作者: Gordon C